Scan to Download
One power score. Smarter investment decisions
Kyverna Therapeutics Inc
KYTX5.800USD
+0.790+15.77%
Close 09/19, 16:00（ET）Quotes delayed by 15 min
USD0.000After-hours (ET)
250.82MMarket Cap
LossP/E TTM
Kyverna Therapeutics Inc
5.800
+0.790+15.77%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q1
FY2022Q4
Total revenue
----
----
----
----
----
----
-100.00%0.00
----
--282.00K
Revenue
----
----
----
----
----
----
-100.00%0.00
----
--282.00K
Operating expenses
32.82%44.41M
59.44%46.81M
91.99%41.04M
--38.77M
--33.44M
156.51%29.36M
136.03%21.38M
--11.45M
--9.06M
R&D expenses
31.09%35.82M
66.55%37.43M
95.09%33.48M
--29.19M
--27.32M
158.02%22.48M
142.86%17.16M
--8.71M
--7.07M
Depreciation, depletion, and amortization
0.00%537.00K
-6.70%501.00K
6.03%563.00K
--558.00K
--537.00K
36.29%537.00K
41.98%531.00K
--394.00K
--374.00K
Other operating expenses
--0.00
---600.00K
----
----
----
----
----
----
----
Operating profit
-32.82%-44.41M
-59.44%-46.81M
-91.99%-41.04M
---38.77M
---33.44M
-156.51%-29.36M
-143.61%-21.38M
---11.45M
---8.78M
Net non-operating interest income (expenses)
Non-operating interest income
-49.64%2.36M
3.29%2.83M
353.11%3.58M
--4.36M
--4.69M
683.67%2.73M
165.66%789.00K
--349.00K
--297.00K
Non-operating interest expense
-64.10%14.00K
-43.18%25.00K
-42.55%27.00K
--33.00K
--39.00K
0.00%44.00K
14.63%47.00K
--44.00K
--41.00K
Special income (expenses)
--0.00
---600.00K
----
----
----
----
----
----
----
Other non-operating income (expenses)
8.70%-21.00K
-3.85%-27.00K
112.50%4.00K
---45.00K
---23.00K
-766.67%-26.00K
-239.13%-32.00K
---3.00K
--23.00K
Income before tax
-46.10%-42.08M
-67.22%-44.63M
-81.40%-37.49M
---34.49M
---28.80M
-139.55%-26.69M
-143.26%-20.67M
---11.14M
---8.50M
Income after tax
-46.10%-42.08M
-67.22%-44.63M
-81.40%-37.49M
---34.49M
---28.80M
-139.55%-26.69M
-143.26%-20.67M
---11.14M
---8.50M
Net income from continuous operations
-46.10%-42.08M
-67.22%-44.63M
-81.40%-37.49M
---34.49M
---28.80M
-139.55%-26.69M
-143.26%-20.67M
---11.14M
---8.50M
Net income attributable to controlling interests
-46.10%-42.08M
-67.22%-44.63M
-81.40%-37.49M
---34.49M
---28.80M
-139.55%-26.69M
-143.26%-20.67M
---11.14M
---8.50M
Net income attributable to common shareholders
-46.10%-42.08M
-67.22%-44.63M
-81.40%-37.49M
---34.49M
---28.80M
-139.55%-26.69M
-143.26%-20.67M
---11.14M
---8.50M
Basic earnings per share
-45.76%-0.97
-66.83%-1.03
-109.77%-0.87
---0.80
---0.67
-126.81%-0.62
-98.63%-0.41
---0.27
---0.21
Diluted earnings per share
-45.76%-0.97
-66.83%-1.03
-109.77%-0.87
---0.80
---0.67
-126.81%-0.62
-98.63%-0.41
---0.27
---0.21
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
